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Galactosemia is a human disease caused by deficient activity of each one of the three enzymes
involved in galactose metabolism, galactokinase (GALK), galactose-1-phosphate uridyl trans-
ferase (GALT) and UDP-galactose-4-epimerase (GALE). Absence or deficiency of GALT acti-
vity results in classical galactosemia. This disorder exhibits allelic heterogeneity in different
populations and ethnic groups. The aim of this study was to search for galactosemia mutations
Q188R, N314D, and K285N in healthy population of Croatia. DNA samples from 221 subjects
were analyzed by the polymerase chain reaction, followed by digestion with restriction endo-
nucleases (PCR-RFLP procedure). Allele frequencies for Q188R, N314D, and K285N were found
to be 0.2 %, 7.5 % and 0 %, respectively, and correlate well with those published for most
other healthy Caucasian populations.
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INTRODUCTION
Galactose is metabolized in three steps, which are cata-
lyzed by galactokinase (GALK), galactose-1-phosphate
uridyl transferase (GALT) and UDP-galactose-4-epime-
rase (GALE).1 Galactose enters energy metabolism due
to its conversion into glucose-1-phosphate by GALT or is
incorporated into glycoproteins and glycolipids as UDP-
galactose, another product of GALT reaction, which is
the substrate of all galactosylation reactions.2
Galactosemia is a human disease caused by deficient
activity of each one of the three enzymes involved in ga-
lactose metabolism. Galactosemia is characterized by a
variety of symptoms such as cataracts, failure to thrive,
vomiting, diarrhoea, hepatomegalia, sepsis, ovarian failure,
which if not treated may lead to death.1
Absence or deficiency of GALT activity results in
classical galactosemia (McKusick 230400).
The human GALT gene is mapped to chromosome
9p13.3 The gene containing 11 exons and spanning 4 kb
has been cloned and sequenced. More than 50 point mu-
tations have been identified by the single-strand confor-
mation polymorphism (SSCP) analysis.4 The most com-
mon classical galactosemia mutation is substitution of glu-
tamine at codon 188 with arginine (Q188R).4–6 This mu-
tation prevails in Caucasian population and has been re-
ported to account for 54 to 70 % of classical galactose-
mia alleles. Homoallelic patients with Q188R mutation
exhibit a complete loss of GALT enzyme activity, but hete-
rozygotes have approximately 50 % of normal GALT acti-
vity. The S135L mutation is the most frequently observed
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mutation in African-Americans and accounts for appro-
ximately 50 % of the mutant alleles in that population.
The K285N mutation is common in individuals of Eastern
European descent and accounts for 8 % of alleles in the
general European population. Homoallelic patients with
this mutation exhibit a complete loss of GALT enzyme
activity, but heterozygotes have approximately 50 % of
normal GALT activity.7 Another two GALT variants are
named after two cities, Duarte (D2 or Duarte-2) and Los
Angeles (D1, Duarte-1 or Los Angeles, LA) where they
were first observed. These variants are caused by the sub-
stitution of asparagine to aspartate at position 314 (N314D).
Both variants are associated with changed electrophore-
tic mobility of GALT due to increased overall negative
charge of mutant protein, but very different enzyme ac-
tivities. D1 is associated with increased GALT activity
(110–130 % of normal activity), and D2 with reduced
activity (about 50 % of normal activity), depending on
additional regulatory genetic changes in the alleles.8,9 It
has been reported that D1 allele also carries the L218L
silent mutation in exon 7, cis with N314D, and D2 alleles,
besides N314D mutation, carry three intronic sequence
variations (IVS), IVS4-27G>C (G1105C), IVS5+62G>A
(G1323A) and IVS5-24G>A (G1391A) in intron 5 toget-
her with 5' promoter deletion – 119_116 del-GTCA.8,10
The D2 variant is present in 5 % of the general U.S. po-
pulation.11,12 Duarte, N314D mutation, when paired with
a classical galactosemia mutation, results in a milder and
probably benign phenotype with approximately 75 % re-
duction in enzyme activity.
Although heterozygotes for classical and Duarte ga-
lactosemia appear to be benign, there are some indica-
tions that these disorders increase the risk of developing
ovarian failure and presenile cataracts later in life.13,14
The aim of the presented study was to analyze healthy
Croatian population for the frequency of galactosemia
alleles Q188R, N314D, K285N, and the intronic variant
IVS5-24G>A. The results of this study provide a basis
for examining groups of patients with diseases associat-
ed with each mutation.
EXPERIMENTAL
Subjects
Two hundred and twenty-one healthy subjects from eastern,
southern and central parts of Croatia were screened for
frequencies of Q188R, N314D, K285N mutations and the
IVS5-24G>A intron variation. The study was approved by
the Ethics Committees of the Clinical Hospital Split, »Dr.
Josip Ben~evi}« General Hospital, Slavonski Brod, and
Clinical Hospital for Lung Diseases, Jordanovac, Zagreb.
Samples
Genomic DNA was extracted from 2.5 ml EDTA blood by
the salting out procedure.15
Polymerase Chain Reaction (PCR)
PCR was performed for four DNA fragments containing po-
tential sites of intron variation (IVS5-24G>A, intron 5) and
Q188R (exon 6), N314D (exon 10), and K285N (exon 9) mu-
tations. Each PCR mixture (total volume 25 ml) contained 250
ng genomic DNA, 0.4 mmol dm–3 of each primer (Microsynth
GmbH), 0.2 mmol dm–3 dNTP (mixture of dATP, dGTP, dCTP,
dTTP; 0.2 mmol dm–3 of each; Pharmacy Biotech), 2 mmol
dm–3 MgCl2 (Invitrogen), PCR buffer (20 mmol dm–3 Tris-HCl
pH = 8.4, 50 mmol dm–3 KCl; Invitrogen) and 0.5 units of
Platinum Taq polymerase (1 unit of Platinum Taq DNA
Polymerase is the amount of enzyme required to incorporate
10 nmol of deoxyribonucleotide into acid-precipitable mate-
rial in 30 minutes at 74 °C; Invitrogen). The following
primers were used in PCRs to amplify:
a) 572 base pairs (bp) fragment containing IVS5-24G>A
intron variant and Q188R mutation,
F: 5'-AACCAGAGTTGGAGACTCAGCA-3',
R: 5'-AGAACAGGCAGGTCCTTTACCT-3';
b) 450 bp fragment containing N314D mutation,
F: 5'-CCTAGTGAACTGCAACCTCAAA-3',
R: 5'-GAGACGCCAGACTGTTCTGAGT-3';
c) 715 bp fragment containing K285N mutation,
F: 5'-GATGGAGGTTGCTCCCAGTA-3',
R: 5'-AGCACAAGGGCAACAGAAGT-3'.16,17
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TABLE I. Frequencies of Q188R, N314D, IVS-24G>A, Duarte- 2, Duarte-1 and K285N mutations in healthy population of Croatia
Q188R N314D
(D1 + D2)
IVS5-24G>A Duarte-2 Duarte-1 K285N
Number of cases 221 221 221 221 221 221
Number of heterozygotes 1 31 19 16 15 0
Number of homozygotes 0 1 0 0 1 0
Number of all alleles 442 442 442 442 442 442
Number of normal alleles 441 409 423 426 425 442
Number of mutated alleles 1 33 19 16 17 0
Frequency of normal alleles / % 99.8 92.5 95.7 96.4 96.2 100.0
Frequency of mutated alleles / % 0.2 7.5 4.3 3.6 3.8 0.0
PCR for all fragments consisted of one cycle of 12 min
at 95 °C, 35 cycles with three steps (first at 94 °C for 30 s,
second at 55 °C for 30 s and third at 72 °C for 60 s) and one
cycle of 7 min at 72 °C. PCR was attenuated by lowering
the temperature to 4 °C for at least 6 min.
Detection of Q188R, N314D, K285N mutations and
the IVS5-24G>A Intron Variant by Restriction
Fragment Length Polymorphism (RFLP)
Amplified DNA fragments were searched for the Q188R mu-
tation based on an additional restriction site for endonuclease
HpaII, which is created by this mutation in exon 6 of the
GALT gene. Likewise, N314D and K285N create additio-
nal restriction sites for AvaII in exon 10 and for Tsp509I in
exon 9 of the GALT gene. Intron variation, IVS5-24G>A,
eliminates the SacI restriction site present in a normal GALT
gene.
Each restriction endonuclease mixture (total volume 15
ml) contained 5 ml of amplified fragment, appropriate buf-
fer for each restriction endonuclease (New England Biolabs)
and 2.5 units of each restriction endonuclease (1 unit of re-
striction enzyme is the amount of enzyme required to digest
1 µg of lambda DNA in 1 hour at appropriate temperature;
New England Biolabs). Restriction products were separated
by electrophoresis (100 V, 60 mA, for 60 min) on 4 % aga-
rose gel (NuSieve® 3:1 Agarose, Cambrex Bio Science Rock-
land, Inc.) in TAE buffer (0.04 mol dm–3 Tris-HCl pH = 7.9,
5 mmol dm–3 Na-acetate, 0.04 mmol dm–3 EDTA). Gels were
stained with ethidium bromide (0.5 mg/ml).
Statistical Analysis
Comparisons of the frequencies of Q188R and K285N mu-
tations were analyzed by the Z-test. The chi-square test was
used for comparisons of the frequencies of N314D (Duarte-1
and Duarte-2) mutation.
RESULTS AND DISCUSSION
In the present study, a healthy population of two hund-
red and twenty-one healthy volunteers from different re-
gions of Croatia was searched for Q188R, N314D, K285N
and IVS5-24G>A mutations in the GALT gene. All the
mentioned mutations were estimated by the PCR-RFLP
procedure.
Frequency of Q188R Mutation
In order to estimate the Q188R mutation in exon 6 of the
GALT gene, the 572 bp fragment was amplified by PCR
using forward and reverse primers as mentioned in Ex-
perimental. Q188R mutation introduces an additional re-
striction site for HpaII endonuclease, giving specific re-
striction fragment patterns after digestion of the amplified
fragment with HpaII. If one allele is mutated (heterozy-
gote, carrier of classical galactosemia allele), restriction
with HpaII generates four fragments of 415, 273, 157 and
142 and, in the case of a normal allele, two fragments of
415 and 157 bp. Figure 1a shows the characteristic re-
striction pattern for heterozygote (lane 1) and normal al-
leles (lanes 3, 4, 5). In fact, in the case of heterozygote,
only three fragments could be detected on stained agarose
gel because 157 and 142 bp fragments were not clearly
separated. Only one mutated allele was found in the group
of 221 healthy subjects. This gave an allele frequency of
0.2 (Table I).
Frequency of Duarte Alleles
Duarte galactosemia (Duarte-1 and Duarte-2) is associat-
ed with N314D mutation in exon 10 of the GALT gene.
N314D mutation was determined by digestion of the am-
plified fragment (450 bp in length) with AvaII restriction
endonuclease. A normal allele gives two restriction frag-
ments of 404 and 46 bp. In the case of the homozygote,
three fragments were observed for this mutation on stain-
ed agarose gel, 302, 102 and 46 bp fragments, as shown
in Figure 1b, lane 2. Heterozygote generated four frag-
ments of 404, 302, 102 and 46 bp (Figure 1b, lanes 3, 4).
One homozygote and 31 heterozygotes were identified in
healthy Croatian population, giving an allele frequency
of 7.5 % (D1 + D2 alleles shown in Table I).
To distinguish between D1 and D2 alleles, we search-
ed for the IVS5-24G>A intron variation, which has been
reported to be associated with D2 galactosemia and not
present in Los Angeles (D1) galactosemia. IVS5-24G>A
mutation eliminates the SacI restriction site present in the
normal intron 5 of the GALT gene. In the studied group,
19 heterozygotes were found for IVS5-24G>A by identi-
fication of specific restriction patterns (fragments of 572,
367 and 215 bp, Figure 1c, lane 1). Two fragments of
367 and 215 bp were observed on stained agarose gel in
the absence of mutation (Figure 1c, lanes 3 and 4). In a
group of 32 subjects with determined N314D mutation
(1 N314D homozygote and 31 N314D heterozygotes), 16
Duarte-2 heterozygotes, 1 Duarte-1 homozygote and 15
Duarte-1 heterozygotes were identified, giving an allele
frequency of 3.6 % for D2 and 3.8 for D1 (Table I).
Searching other subjects, without N314D mutation, we
found another three heterozygotes for the IVS5-24G>A
intron variation.
Frequency of K285N Mutation
221 healthy subjects were searched for K285N, which
creates additional restriction sites for Tsp509I in exon 9
of the GALT gene. The restriction pattern of normal al-
leles is shown in Figure 1d, lanes 2, 3, 4, including frag-
ments of 573 and 142 bp. No mutated alleles were iden-
tified in the studied group of subjects.
Frequencies of Q188R, N314D, and K285N mutations
found in healthy population of Croatia were compared
with the published data on other healthy populations of
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Figure 1. Detection of galactosemia mutations by the RFLP-PCR procedure. (a) Detection of Q188R allele. Lane 1: Q188R heterozygote
(QR alleles, fragments of 415, 273 and 157 bp); lane 2: undigested PCR fragment of 572 bp; lanes 3, 4, 5: no Q188R mutation (QQ
normal alleles; fragments of 415 and 157 bp). (b) Detection of N314D allele. Lane 1: undigested PCR fragment of 450 bp; lane 2:
N314D homozygote (DD alleles, fragments of 302, 102 and 46 bp); lanes 3, 4: N314D heterozygote (ND alleles, fragments of 404,
302, 102 and 46 bp). (c) Detection of IVS5-24G>A allele. Lane 1: VS5-24G>A heterozygote (GA alleles, fragments of 572, 367 and
215 bp); lane 2: undigested PCR fragment of 572 bp; lanes 3, 4: no intron mutations (GG alleles, fragments of 367 and 215 bp).
(d) Detection of K285N allele. Lane 1: undigested PCR fragment of 715 bp; lanes 2, 3, 4: no K285N mutation (KK alleles, fragments of
573 and 142 bp).
TABLE II. Allele frequencies of Q188R, N314D, and K285N mutations in different healthy populations. Results of screening healthy
population of Croatia for galactosemia mutations are compared with published data on other healthy populations
Q188R N314D (D1 + D2) N314D-D2 N314D-D1 K285N
Region, country,
population
n
Allele
frequency
%
P
Allele
frequency
%
P
Allele
frequency
%
P
Allele
frequency
%
P
Allele
frequency
%
P
Croatia 221 0.20 7.5 3.6 3.8 0.0
Slovenia 174 0.29 0.634 (a) 8.0 0.866 (b) 5.7 0.211 (b) 2.3 0.304(b) 0.29 (c) 0.683 (a)
Germany 289 - - 14.9 <0.001 (b) 9.7 <0.001 (b) 5.2 0.388 (b) - -
Czech Republic 504 - - 8.2 0.696 (b) 5.4 0.198 2.8 0.360 (b) - -
Italy 802 - - 7.7 0.933 (b) 3.7 0.932 (b) 4.0 1.000 (b) - -
UK 248 - - 8.9 0.507 (b) - - - - - -
Eastern Europe 254 0.098 0.659 (a) - - - - - - - -
Western Europe 1887 0.28 0.859 (a) - - - - - - - -
Northern Europe 277 0.90 0.309 (a) - - - - - - - -
Southern Europe 176 0.28 0.613 (a) - - - - - - - -
USA: average of
all populations
4796 0.23 0.704 (a) 7.8 0.870 (b) 5.1 0.201 (b) 2.7 0.197 (b) 0.042 0.433 (a)
USA: Caucasian
population
3244 0.29 0.906 (a) 8.8 0.831 (b) 6.0 0.051 (b) 2.8 0.262 (b) 0.062 0.619 (a)
(a) P value obtained by Z-test; (b) P value obtained by c-test; (c) Number of cases analyzed for K285N mutation: 346.
Europe and the USA, as shown in Table II.10,16,18–22 Fre-
quencies of all searched galactosemia mutations in healthy
population of Croatia correlate well with those reported
for healthy populations of Slovenia, the Czech Republic,
Italy, the UK, Eastern, Western, Northern and Southern
Europe, and the USA (USA-Caucasian population).10,16,18–22
There is a statistically significant difference (p< 0.001)
between Croatian and German populations concerning the
N314D mutation, particularly Duarte-2.
Duarte allele is the most frequent galactosemia allele
in healthy population of Croatia, followed by Q188R, the
classical galactosemia allele. Although heterozygotes for
classical and Duarte galactosemia appear to be benign,
there are some indications that these mutations increase
the risk of developing some diseases, such as ovarian fail-
ure and presenile cataracts.13,14 Results of the presented
study provide a basis for further investigation of the as-
sociation of galactosemia mutations with some diseases.
On the other hand, these results seem to be useful for ra-
tional neonatal screening for the most frequent galacto-
semia alleles in Croatia.
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Pojavnost mutacija u genu za galaktoza-1-fosfat uridil transferazu
u zdravoj populaciji u Hrvatskoj
Karmela Bari{i}, Lada Rumora, Marija Grdi} i Dubravka Jureti}
Galaktozemija je bolest uzrokovana nedostatkom jednog od tri enzima koji sudjeluju u metabolizmu galak-
toze, galaktokinaze (GALK), galaktoza-1-fosfat uridil transferaze (GALT) ili galaktoza-4 epimeraze (GALE).
Nedostatak ili smanjena kataliti~ka aktivnost GALT-a uzroci su klasi~ne galaktozemije. Budu}i da klasi~na ga-
laktozemija pokazuje alelnu heterogenost u razli~itim populacijama i etni~kim skupinama, cilj ovog istra`ivanja
bio je utvrditi pojavnost alela za Q188R, N314D i K285N mutacije u zdravoj populaciji u Hrvatskoj. Istra`ivanje
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je obuhvatilo 221 zdravu osobu. Iz periferne krvi izolirana je DNA te utvr|ena prisutnost mutacija postupkom
koji je obuhva}ao umno`avanje dijela DNA lan~anom polimerznom reakcijom nakon koje je slijedila digestija
restrikcijskim endonukleazama (PCR-RFLP postupak). Utvr|ena je sljede}a pojavnost mutacija: Q188R 0,2 %,
N314D 7,5 % te 0 % za K285N. Dobiveni rezultati ne razlikuju se od literaturnih podataka objavljenih za ve}i-
nu populacija kavkaskoga podrijetla.
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